SEC Form 4 · accession 0001193125-26-267833
FRACTYL HEALTH, INC. · GUTS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Harith Rajagopalan
Officer — Chief Executive Officer · Director
Period of report
Jun 10, 2026
Accepted (ET)
Jun 11, 2026 · 4:59 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001572616
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2,F3 | Jun 10, 2026 | P | 25,000 | $0.7301 | A | 540,557 | D | |
| Common Stock | holding | — | — | — | 292,171 | I | By 2021 Irrevocable Trust | |
| Common Stock | holding | — | — | — | 292,170 | I | By 2016 Irrevocable Trust | |
| Common Stock | holding | — | — | — | 18,639 | I | By 2021 Family Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Open market purchase.
- F2The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.7213 to $0.7324, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- F3Includes 13,812 shares of common stock purchased pursuant to the Issuer's 2024 Employee Stock Purchase Plan (ESPP) on January 30, 2026, at a purchase price of $0.391 per share.